Experian profits edge higher on strong performance in North America

The credit checker said it expects a "further strong performance" in fiscal year 2020

Experian raised its total dividend for the year by 4%

Credit checking firm Experian PLC (LON:EXPN) posted a 1% rise in 2019 pre-tax profit as revenue growth offset higher costs.

Pre-tax profit rose to US$957mln in the year to the end of March from US$950mln last year.

Revenue increased 6% to US$4.8bn with organic revenue up 9%, led by strong demand in North America and the Asia Pacific and European, Middle East and Africa regions.

READ: Experian abandons Clearscore deal after CMA objections

Consumer services organic revenue edged up 6% while business to business gained 9%.

Finance costs rose by US$99mln, due to an increase in non-cash foreign exchange revaluations on Brazilian real intra-group funding of US$25mln and fair value losses on derivatives.

Experian recommended a total dividend of 46.5 cents, up 4% on the previous year.

“Full-year 2020 is expected to deliver further strong performance, with organic revenue growth in the 6-8% range, benchmark EBIT growth at or above revenue growth and strong progress in benchmark earnings per share,” said chief executive Brian Cassin.

Shares dropped 1.8% to 2,169p in morning trading.

Steve Clayton, manager of the Hargreaves Lansdown Select UK Growth Shares fund, which holds a 4.3% stake in Experian, said the results were hard to fault.

“Underlying organic revenue and earnings per share growth of 9% is better than most businesses will manage in the current environment and the outlook for more of the same is encouraging,” he said.

“The shares had already risen about 15% this year and today’s price move (the shares have opened about 1% lower in early trading) is all about travelling and arriving. “

Quick facts: Experian

Price: 2813 GBX

Market: LSE
Market Cap: £25.55 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



ioneer Ltd's Bernard Rowe hails new boric acid distribution and sales agreements

ioneer Ltd's (ASX:INR) Bernard Rowe speaks to Proactive's Andrew Scott after securing two distribution and sales agreements for the supply of boric acid from its Rhyolite Ridge Lithium-Boron Project in Nevada, USA. The three-year boric acid distribution and sales agreements were signed with...

2 days, 5 hours ago

2 min read